Literature DB >> 29406621

MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.

Adrian P Mansini1,2, Maria J Lorenzo Pisarello3, Kristen M Thelen1, Maetzin Cruz-Reyes1, Estanislao Peixoto1,2, Sujeong Jin1, Brynn N Howard3, Christy E Trussoni3, Gabriella B Gajdos3, Nicholas F LaRusso3, Maria J Perugorria4, Jesus M Banales4, Sergio A Gradilone1,2.   

Abstract

Cholangiocytes normally express primary cilia, a multisensory organelle that detects signals from the cellular environment. Cilia are significantly reduced in cholangiocarcinoma (CCA) by a mechanism involving overexpression of histone deacetylase 6 (HDAC6). Despite HDAC6 overexpression in CCA, we found no differences in its mRNA level, suggesting a posttranscriptional regulation, possibly involving microRNAs (miRNAs). Here, we describe that at least two HDAC6-targeting miRNAs, miR-433 and miR-22, are down-regulated in CCA both in vitro and in vivo. Experimental restoration of these miRNAs in CCA cells reduced HDAC6 expression, induced ciliary restoration, and decreased the malignant phenotype. Furthermore, in contrast to the mature forms, levels of precursor forms of these miRNAs were higher in CCA compared to normal cholangiocytes and accumulated in the nuclei, suggesting a defective nuclear export. We assessed the expression of Exportin-5, the protein responsible for transporting miRNA precursors out of the nucleus, and found it to be reduced by 50% in CCA compared to normal cholangiocytes. Experimental overexpression of Exportin-5 in CCA cells restored precursor and mature forms of these miRNAs to normal levels, inducing a decrease in the expression of HDAC6 and a decrease in the malignant phenotype. Conversely, short hairpin RNA (shRNA) depletion of Exportin-5 in normal cholangiocytes resulted in increased nuclear retention of precursor miRNAs, decreased mature miRNAs, increased cell proliferation, and shorter cilia.
CONCLUSION: These data suggest that down-regulated Exportin-5 impairs the nuclear export of miR-433 and miR-22 precursor forms, causing a decrease in levels of mature miR-433 and miR-22 forms, and leading to overexpression of HDAC6 and ciliary loss in CCA. (Hepatology 2018).
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29406621      PMCID: PMC6078832          DOI: 10.1002/hep.29832

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors.

Authors:  Anatoliy I Masyuk; Sergio A Gradilone; Jesus M Banales; Bing Q Huang; Tatyana V Masyuk; Seung-Ok Lee; Patrick L Splinter; Angela J Stroope; Nicholas F Larusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-07       Impact factor: 4.052

2.  Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.

Authors:  Young-Kook Kim; Boseon Kim; V Narry Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

3.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.

Authors:  Sonia A Melo; Catia Moutinho; Santiago Ropero; George A Calin; Simona Rossi; Riccardo Spizzo; Agustin F Fernandez; Veronica Davalos; Alberto Villanueva; Guillermo Montoya; Hiroyuki Yamamoto; Simo Schwartz; Manel Esteller
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

5.  A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.

Authors:  M Miyagiwa; T Ichida; T Tokiwa; J Sato; H Sasaki
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

6.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

7.  Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma.

Authors:  Yandong Li; Xiao Wang; Bin He; Hui Cai; Yong Gao
Journal:  Mol Cell Biochem       Date:  2016-03-21       Impact factor: 3.396

8.  Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Authors:  Yuchen Jiao; Timothy M Pawlik; Robert A Anders; Florin M Selaru; Mirte M Streppel; Donald J Lucas; Noushin Niknafs; Violeta Beleva Guthrie; Anirban Maitra; Pedram Argani; G Johan A Offerhaus; Juan Carlos Roa; Lewis R Roberts; Gregory J Gores; Irinel Popescu; Sorin T Alexandrescu; Simona Dima; Matteo Fassan; Michele Simbolo; Andrea Mafficini; Paola Capelli; Rita T Lawlor; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa; William Jarnagin; David Klimstra; Rachel Karchin; Victor E Velculescu; Ralph H Hruban; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Laura D Wood
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

9.  Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.

Authors:  Dengwen Li; Xiaodong Sun; Linlin Zhang; Bing Yan; Songbo Xie; Ruming Liu; Min Liu; Jun Zhou
Journal:  Protein Cell       Date:  2014-01-29       Impact factor: 14.870

Review 10.  MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment.

Authors:  Maria Jose Lorenzo Pisarello; Lorena Loarca; Tommy Ivanics; Leslie Morton; Nicholas LaRusso
Journal:  J Clin Med       Date:  2015-08-26       Impact factor: 4.241

View more
  27 in total

1.  MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants.

Authors:  Vik Meadows; Heather Francis
Journal:  AME Med J       Date:  2018-10-04

Review 2.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 3.  The primary cilium: Its role as a tumor suppressor organelle.

Authors:  Estanislao Peixoto; Seth Richard; Kishor Pant; Aalekhya Biswas; Sergio A Gradilone
Journal:  Biochem Pharmacol       Date:  2020-03-10       Impact factor: 5.858

4.  The Chemosensory Function of Primary Cilia Regulates Cholangiocyte Migration, Invasion, and Tumor Growth.

Authors:  Adrian P Mansini; Estanislao Peixoto; Sujeong Jin; Seth Richard; Sergio A Gradilone
Journal:  Hepatology       Date:  2019-03-15       Impact factor: 17.425

Review 5.  Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Authors:  Antonio Cigliano; Xin Chen; Diego F Calvisi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-04-23       Impact factor: 3.869

Review 6.  P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Authors:  Lucas T Woods; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Gary A Weisman
Journal:  Biochem Pharmacol       Date:  2021-01-04       Impact factor: 5.858

Review 7.  The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Li Wang
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

8.  MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.

Authors:  Angelisa Frasca; Eleonora Spiombi; Michela Palmieri; Elena Albizzati; Maria Maddalena Valente; Anna Bergo; Barbara Leva; Charlotte Kilstrup-Nielsen; Federico Bianchi; Valerio Di Carlo; Ferdinando Di Cunto; Nicoletta Landsberger
Journal:  EMBO Mol Med       Date:  2020-05-08       Impact factor: 12.137

9.  MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.

Authors:  Weiping Chang; Yuan Wang; WenZhi Li; Lei Shi; Zhimin Geng
Journal:  J Cell Mol Med       Date:  2019-06-14       Impact factor: 5.310

Review 10.  The Role of Primary Cilia in Thyroid Cancer: From Basic Research to Clinical Applications.

Authors:  Cheng-Xu Ma; Xiao-Ni Ma; Ying-Dong Li; Song-Bo Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.